3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
32
Breast Neoplasms
25
Lung Neoplasms
12
Pain
11
Agnosia
11
Leiomyoma
7
Pancreatic Neoplasms
5
Neoplasms
5
Prostatic Neoplasms
4
Colorectal Neoplasms
4
Rectal Neoplasms
3
Neuroma
3
Neuralgia
3
Hot Flashes
3
Colonic Neoplasms
3
Thyroid Nodule
2
Thyroid Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphedema
2
Liver Neoplasms
2
Kidney Neoplasms
2
Ileus
2
Hyperparathyroidism
2
Goiter
2
Digestive System Diseases
2
Chronic Pain
2
Breast Cancer Female
2
Brain Neoplasms
2
Adenomyosis
2
Abdominal Cancer
2
Interventions
Surveys and Questionnaires
2
Oxaliplatin
2
Cyclophosphamide
2
Colonoscopy
2
Capecitabine
2
Aspirin
2
pembrolizumab
1
lutetium Lu 177 dotatate
1
guadecitabine
1
copper dotatate CU-64
1
Ursodeoxycholic Acid
1
Oviposition
1
Lutetium-177
1
Lutetium
1
Irinotecan
1
Folfox protocol
1
Exercise
1
Drainage
1
Chemoradiotherapy
1
Cetuximab
1
Celecoxib
1
Calcium Dobesilate
1
Bupivacaine
1
Biofeedback, Psychology
1
Ascorbic Acid
1
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Intestinal Diseases
×
Bupivacaine
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts